| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.57B | 83.96B | 75.63B | 70.61B | 59.51B | 48.72B |
| Gross Profit | 39.68B | 41.13B | 34.75B | 28.45B | 23.85B | 18.61B |
| EBITDA | 11.15B | 11.24B | 7.45B | 6.10B | 4.27B | 1.18B |
| Net Income | 6.00B | 6.16B | 3.71B | 2.81B | 2.35B | -301.25M |
Balance Sheet | ||||||
| Total Assets | 75.80B | 76.17B | 75.72B | 69.79B | 60.86B | 50.84B |
| Cash, Cash Equivalents and Short-Term Investments | 14.43B | 15.45B | 17.37B | 10.49B | 8.97B | 10.84B |
| Total Debt | 22.07B | 22.94B | 28.50B | 28.85B | 23.87B | 17.48B |
| Total Liabilities | 42.99B | 43.80B | 48.33B | 47.73B | 42.14B | 34.63B |
| Stockholders Equity | 32.64B | 32.22B | 27.26B | 21.99B | 18.67B | 16.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.81B | 7.91B | -1.72B | -6.35B | 6.20B |
| Operating Cash Flow | 0.00 | 7.86B | 9.56B | 490.41M | -5.13B | 6.63B |
| Investing Cash Flow | 0.00 | -2.44B | -2.60B | -3.50B | -2.71B | 15.94M |
| Financing Cash Flow | 0.00 | -7.54B | -1.44B | 3.52B | 4.28B | -7.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥188.09B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥277.64B | 10.08 | ― | 3.08% | 22.81% | 504.99% | |
74 Outperform | ¥49.55B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
66 Neutral | ¥47.13B | 6.70 | ― | 3.07% | 1.56% | 1.72% | |
65 Neutral | ¥30.21B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
64 Neutral | ¥14.40B | 25.64 | ― | 4.62% | -2.98% | 4.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |